We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Systems Offer Cost-Effective Urinalysis at Any Lab Scale

By LabMedica International staff writers
Posted on 22 Jul 2019
Image: The LAURA automated urine analyzer (Photo courtesy of Erba Mannheim).
Image: The LAURA automated urine analyzer (Photo courtesy of Erba Mannheim).
Image: The LAURA XL automated urine analyzer (Photo courtesy of Erba Mannheim).
Image: The LAURA XL automated urine analyzer (Photo courtesy of Erba Mannheim).
With the growing prevalence of kidney-related diseases, proper screening and detection have become an increasing priority for clinicians. Two newly introduced systems, LAURA and LAURA XL, now aim to fill the need for such reliable, automated, and affordable urinalysis.

LAURA is a semi-automated strip reader using reflectance photometry for objective evaluation of color reactions on diagnostic pads. It offers evaluation of 12 clinically significant parameters: specific gravity, leukocytes, nitrites, pH, protein, glucose, ketones, urobilinogen, bilirubin, blood, microalbumin, and creatinine, as well as calculation of protein/creatinine ratio.

The instrument operates with continuous loading and throughput of 400 tests per hour. Convenient sample identification and data input via barcode reader and LIS connectivity minimize potential data management errors and reflect the need for increased efficiency and safety. The intuitive user interface has been designed to offer a broad range of optimized features such as results flagging and recommendation for additional sediment evaluation or customized reporting options.

Overall, the LAURA reader, with PHAN diagnostic strips and URINORM control urines, provides a complete solution to optimize laboratory workflow. This instrument offers affordable automation for smaller and mid-sized labs, or serves as reliable backup system for fully automated larger labs.

The LAURA XL is a fully automated urine analyzer combining trusted urine strip analysis and digital microscopy. It offers automatic evaluation of 10 chemistry parameters and 16 sediment categories. In addition, users can select from 16 manual and four customizable sediment categories. Concentration of sediment particles is achieved without centrifugation by gravitational sedimentation.

This is a very gentle technique preventing damage of fragile elements and allowing cost-effective measurement by replacing disposable cuvettes with a long-life, washable cuvette module. Due to clear high-resolution imagery, LAURA XL reduces the need for additional evaluation of results by visual microscopy.

The LAURA XL system - a powerful tool for larger labs looking for a high-performance solution to automate their routine urinalysis requirements - is delivered with special adaptors, which enable measurement of low volume samples - minimal volume for analysis of both urine chemistry and sediment is then 0.9 microliters of urine. It operates in three modes: chemistry only (180 tests/hour), sediment only (140 tests/hour), and hybrid (140 tests/hour).

The LAURA and LAURA XL clinical urinalysis systems were developed and are being introduced by Erba Mannheim (Mannheim, Germany), a global IVD company focused on delivering total solutions for clinical diagnostics.


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more